Supplementary Table S3 from Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma

Authors :: Yi-Long Wu
Si-Pei Wu
Ri-Qiang Liao
Li-Xu Yan
Hao-Ran Zhai
Hong-Hong Yan
Jia-Xin Lin
Xue-Ning Yang
Jin-Ji Yang
Qing Zhou
Yue-Li Sun
Hua-Jun Chen
Hai-Yan Tu
Si-Yang Liu
Zhi Xie
Jian Su
Xu-Chao Zhang
Wen-Zhao Zhong
Zhong-Yi Dong
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Demographics and clinical characteristics of 93 ADC patients according to PD-L1 expression.

Full Text Access

Tools